$697K

SANOFI VACCINES US INC.

PA
Contract FY2026
75A50126F61013
$697K
Obligated Amount
Award Value
Outlayed
May 8, 2026
Action Date
End Date
NAICS Code
FY2026
Fiscal Year

Contract Description

Two-way immunogenicity testing on existing clinical trial sera to confirm immunogenicity superiority of a new vaccine strain versus the prototype strain

Award Details

Awarding Agency Department of Health and Human Services
Sub-Agency Office of Assistant Secretary for Preparedness and Response
Contract Type Contract
Period May 8, 2026

Recipient

Recipient name, address, UEI, and contact info are part of the Basic plan and above.
Upgrade to see who won

Place of Performance

City / State PA

Search Similar

Same in Pennsylvania

Transaction History

Mod # Date Amount Action Type Description
May 8, 2026 $697K Two-way immunogenicity testing on existing clinical trial sera to confirm imm...
May 8, 2026 $697K Two-way immunogenicity testing on existing clinical trial sera to confirm imm...
Apr 3, 2026 $450K Two-way immunogenicity testing on existing clinical trial sera to confirm imm...

About This Contract

This contract was awarded to SANOFI VACCINES US INC. (based in Pennsylvania) by Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response sub-agency. The award represents one of millions of federal procurement actions tracked through USASpending.gov, the official source of federal spending data.

The obligated amount is $697,439. Federal contract obligations represent funds committed by the government for goods or services. Actual outlays may differ if contract modifications, terminations, or scope changes occur during the period of performance.

The place of performance for this contract is Pennsylvania. Federal contracts are distributed across all 50 states, with concentrations in defense corridors and metropolitan areas hosting major federal facilities.